Diabetes drug may be game changer
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Getting a grip on diabetes: Aptitude device gets fast track status for clinical trials
Aptitude creates a special type of molecule called an aptamer, which it is using to develop a first-of-its-kind hand-held device that measures insulin concentrations in real-time and can diagnose pre-diabetes. The government’s interest in furthering such research is unsurprising as diabetes affects more than 9 percent of Americans.
A heartbeat away: Advances in diabetes tech promise better self-care
In May 1922, Dr. William Sansum injected a diabetes patient with insulin for the first time in the U.S., instantly increasing life expectancy from mere weeks to many years. His patient lived to 90.
Active Life device finds link between diabetes, bone issues
A device made by Santa Barbara-based Active Life Scientific played a critical role in a new study at the Mayo Clinic linking Type 2 diabetes to bone problems.
Study targets diabetes
New research conducted on the South Coast could point the way to the prevention and cure of type two diabetes.
